VanEck Pharmaceutical ETF (PPH) |
| 106.08 0.617 (0.59%) 01-14 13:15 |
| Open: | 105.92 |
| High: | 106.49 |
| Low: | 105.725 |
| Volume: | 97,724 |
| Market Cap: | 626(M) |
| PE Ratio: | 23.23 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 125.35 |
| Resistance 1: | 107.32 |
| Pivot price: | 104.60 |
| Support 1: | 101.26 |
| Support 2: | 97.52 |
| 52w High: | 107.28 |
| 52w Low: | 77.67 |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 25 Dec 2025
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Tue, 23 Dec 2025
Why Are Investors Re-Evaluating Large Pharmaceutical Companies? - VanEck
Wed, 17 Dec 2025
Why PPH Keeps Working When Single Themes Break (NASDAQ:PPH) - Seeking Alpha
Thu, 27 Nov 2025
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Mon, 13 Oct 2025
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - The Motley Fool
Mon, 06 Oct 2025
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - Zacks Investment Research
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
